Ironwood Pharmaceuticals IRWD Current liabilities
Current liabilities at other companies
Other financials
Where this comes from
Reported directly by Ironwood Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherCurrentLiabilities.
The official record: Ironwood Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ironwood Pharmaceuticals's current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Ironwood Pharmaceuticals's current liabilities?
- Ironwood Pharmaceuticals (IRWD) reported current liabilities of -$219K in Q1 2026.
- How has Ironwood Pharmaceuticals's current liabilities changed year-over-year?
- Ironwood Pharmaceuticals's current liabilities decreased by 217.1% year-over-year, from $187K to -$219K.
- What is the long-term trend for Ironwood Pharmaceuticals's current liabilities?
- Over 3 years (2021 to 2025), Ironwood Pharmaceuticals's current liabilities has grown at a 43.8% compound annual growth rate (CAGR), from -$1.38M to $4.11M.